Botto J M, Chabry J, Sarret P, Vincent J P, Mazella J
Institut de Pharmacologie Moléculaire et Cellulaire, CNRS UPR 411, Valbonne, France.
Biochem Biophys Res Commun. 1998 Feb 13;243(2):585-90. doi: 10.1006/bbrc.1997.8071.
The recently cloned new subtype of G protein-coupled neurotensin receptor (NTRL) was stably expressed in the HEK 293 cell line in order to investigate its binding and internalization properties. The expressed receptor exhibited the typical binding characteristics of the low affinity, levocabastine-sensitive binding site previously described in rat and mouse brain and was detected as a protein with an apparent MW of 45 kDa by photoaffinity labeling. Although intracellular modulation of adenylate cyclase, guanylate cyclase and phospholipase C was not detected after application of neurotensin or levocabastine on NTRL-transfected cells, this receptor was able to internalize iodinated neurotensin. The internalization process was followed by recycling of receptors to the cell membrane. By contrast, no recycling was observed with the high affinity neurotensin receptor (NTRH). The differential intracellular routing of NTRH and NTRL after internalization is most probably the consequence of their divergent carboxy-terminal sequences.
为了研究其结合和内化特性,最近克隆的G蛋白偶联神经降压素受体(NTRL)新亚型在HEK 293细胞系中稳定表达。所表达的受体表现出先前在大鼠和小鼠脑中描述的低亲和力、左卡巴斯汀敏感结合位点的典型结合特征,并且通过光亲和标记检测为表观分子量为45 kDa的蛋白质。尽管在NTRL转染细胞上应用神经降压素或左卡巴斯汀后未检测到腺苷酸环化酶、鸟苷酸环化酶和磷脂酶C的细胞内调节,但该受体能够内化碘化神经降压素。内化过程之后是受体循环回到细胞膜。相比之下,高亲和力神经降压素受体(NTRH)未观察到循环。内化后NTRH和NTRL不同的细胞内途径很可能是它们不同的羧基末端序列的结果。